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Usefulness of the patient information leaflet 
(PIL) and information on medicines from 
professionals: A patients’ view. A qualitative 
study
Uporabnost pisne informacije o zdravilu (pmil) 
in informacije o zdravilih, ki jih poda strokovnjak: 
pogled bolnikov. Kvalitativna študija
Tonka Poplas-Susič,1,2 Zalika Klemenc-Ketis,3 Janko Kersnik2,3
Izvleček
Izhodišče: Informacija o zdravilu za bolnika 
(PMIL) je pomemben vir informacij o zdravilih. 
Manj je znano, ali bolniki ta navodila berejo in, 
ali pri tem dobijo potrebne informacije. Bolniki 
dobivajo ustrezne informacije tudi od strokov-
njakov (zdravnik, farmacevt, medicinska sestra). 
Informiranje bolnika o zdravilu je pomemben 
dejavnik, ki pozitivno vpliva na komplianco.
Namen študije je preveriti uporabnost PMIL z 
vidika bolnika in ugotoviti, katerim drugim vi-
rom informacij o zdravilih bolniki zaupajo ter 
predlagati izboljšave, ki bodo pri bolnikih pove-
čale informiranost in s tem komplianco.
Metode: 4 fokusne skupine so bile oblikovane v 
različnih zdravstvenih zavodih v severovzhodni 
Sloveniji. Udeleženci, skupaj 20, so bili naključni 
bolniki, ki so bili pripravljeni izraziti svoja stali-
šča o PMIL, o drugih virih informacij o zdravilih 
in o možnih spremembah. Pogovori so bili po-
sneti in po prepisu je bilo besedilo analizirano 
po kakovosti.
Rezultati: Bolniki berejo PMIL selektivno: naj-
bolj jih zanimajo stranski učinki, kontraindi-
kacije in namen, zakaj se zdravilo uporablja. 
Bolniki so poudarili, da je jezik v PMIL preveč 
strokoven. Če ne razumejo prebranega ali prepo-
znajo stranski učinek, se večina bolnikov odloči 
poiskati izbranega zdravnika in precej manjkrat 
medicinsko sestro ali farmacevta. Zdravnik jim 
je najbolj zanesljiv vir informacij. Menijo pa, da 
bi farmacevti lahko zavzemali bolj dejavno vlogo 
pri poučevanju o zdravilih.
Zaključek: PMIL nudi zadosti delnih odgovo-
rov, vendar bolniki v njem ne dobijo celovite in-
formacije o zdravilu glede na svoje zdravstveno 
stanje, zato ga nimajo kot zadostni vir informa-
cij. V PMIL pogrešajo večji poudarek ključnim 
informacijam in boljšo čitljivost besedila. Naj-
bolj zanesljiv vir informacij o zdravilih je zanje 
družinski zdravnik. Farmacevti bi lahko prevzeli 
dejavnejšo vlogo pri poučevanju bolnikov.
Abstract
Background: The Patient information leaflet 
(PIL) is an important source of information for 
every patient. Little is known about whether pa-
tients read the PIL and whether it contains use-
ful information. Other sources of drug-related 
information are professionals (a family practi-
tioner, a pharmacist and a nurse). Informing pa-
tients on drugs improves their compliance.
The aim of the study was to identify the useful-
ness of PIL from the perspective of the patient, 
to assess professionals as a source of drug-related 
information and to suggest changes that can im-
prove informing and therefore patients’ compli-
ances.
Methods: Four focus group interviews were con-
ducted across different primary health care cen-
tres in the North East of Slovenia. Focus groups 
were composed of randomly selected patients (in 
total 20) who were willing to express their views 
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on PILs, on other drug information sources and 
on possible improvements. A qualitative analysis 
of the data was based of the transcription of the 
audiotapes.
Results: Patients read the PILs selectively. They 
were most interested in side effects, contraindi-
cations and the purpose of the prescribed drug. 
Participants reported that the language in PILs is 
too scientific. In the case they do not understand 
PILs or they recognise some of the side effects, a 
majority of participants decide to contact a fam-
ily physician first, and less frequently a pharma-
cist or a nurse. A family physician is considered 
to be the most trustworthy source of information 
and patients think that pharmacists could play a 
more active role in patients’ education.
Conclusion: Current PILs offer enough partial 
information to patients but need some improve-
ments in terms of better legibility and access to 
the most crucial information. PIL does not en-
able a comprehensive information with respect 
to patient’s health status. Most reliable source of 
information is considered to be a family practi-
tioner. Pharmacists could play a more active role 
in the education of patients.
Introduction
Modern medicine is based on treatment 
with medications. The majority of prescrip-
tion drugs are prescribed in family practi-
ces, therefore great responsibility for effec-
tive and rational prescribing lies with family 
doctors.1 In Slovenia, 16,242,776 prescripti-
ons were used in a population of 2 million in 
2012, and patients received on average two 
prescription drugs each time.2,3 75 % of fa-
mily practice patients kept prescription dru-
gs and 64 % kept over-the-counter (OTC) 
drugs stored at home and used them for 
self-medication in 83.6 %.4,5 The use of OTC 
drugs in the Slovenian student population 
for self-medication is even higher (92.3 %) 
and also higher than what is reported in stu-
dies from other cultures and populations.6-8 
Therefore, communicating with patients ef-
fectively and educating them about drugs 
contributes to better knowledge of drugs, 
which is assumed to enhance patient adhe-
rence to treatment.9,10
Written materials extend communica-
tion beyond the time of the actual consul-
tation time and enables patients to become 
more familiar with all aspects of the drug 
taken. Patient information leaflets (PILs), 
which are attached to each packaging of 
drugs, are an important source of informati-
on for every patient. They are derived from 
the Summary of Product Characteristics 
(SmPC) and tailored to the needs of patients 
but often the terminology is too vague to be 
helpful for patients.11,12
Findings from Israel show that 51.5 % re-
spondents read PILs, which in 34.9 % cau-
sed some doubts and could have diminished 
their adherence to treatment.13 In the USA, 
when a new drug was prescribed, 56.2 % of 
patients who read PMIL understood the 
provided information well and in 63.8 % eva-
luated it as useful.14 PIL must be designed 
in such a way that 90 % of adult population 
can understand the information provided.15 
User-friendly design improves patient ad-
herence.16 Patients in the UK have some 
difficulties in understanding PILs’ chapters 
on the interaction of drugs and contraindi-
cations.17 The same is true also when picto-
grams and illustrations are added to PILs, 
especially when patients over 65 years read 
them.18
Family practitioners are considered to be 
a very thrustworthy source of drug-related 
information for patients and they influence 
patients’ decision on medicine taking.19-21 
Communication with patients and their 
inclusion in the treatment improves health 
outcome. In Slovenia, a time for doctor-pa-
tient consultation in family practice in very 
limited and it is not known whether patients 
obtain the information sought.
However, we currently have no account 
of the actual attitude of patients towards 
PILs, how they use and understand them 
and from who do they get useful informa-
tion on drugs.
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Aim of the study
The aim of the study was to discover the 
patients’ views on the usefulness and quality 
of PILs and to investigate who is considered 
to be the most important source of informa-
tion on medications for patients in Slovenia. 
On the basis of these findings, improve-
ments will be suggested.
Methods
Family doctors from different regions 
(rural, urban) in the north-east of Slovenia 
recruited patients on a preselected day in a 
week by asking each fifth patient to take part 
in the study (random selection). The inclu-
sion criteria were ability to communicate 
one’s own views (targeted selection), absen-
ce of psychiatric illnesses and drug/alcohol 
dependence, adequate hearing ability and 
adequate mobility. 42 patients were asked to 
participate and 20 of these responded. Each 
patient received a written information lea-
flet on the study protocol and the approval 
of the National Ethics Committee. Partici-
pants signed a consent form. They were in-
formed by phone of the time and location of 
a group meeting.
We formed four focus groups: 6 women 
(30–45 years old), 5 women (45–60 years 
old), 2 men and 2 women (30–45 years old) 
and 3 men and 2 women (58–73 years old).
The participants neither knew the mode-
rator or the observer nor did they know each 
other. Each discussion lasted approximately 
50 minutes. Participants were asked the fol-
lowing questions: “Do you read medication 
leaflets?”, “Do you take into account the in-
formation you have read?”, “Is the provided 
information useful and clear?” “Who offers 
you the most reliable information about 
drugs?”, Who else do you think can also in-
form you about drugs?, and “Are there any 
other issues we might have missed?”
After each discussion, which was audio-
-taped and then transcribed for qualitative 
analysis, the moderator and the observer 
met and exchanged information on the pro-
cess. When the views began to repeat in the 
focus group and no new ideas on the subject 
were offered, we stopped running new gro-
ups.22,23
The content was analysed by two resear-
chers and monitored by a supervisor expe-
rienced in qualitative analysis. Coding was 
performed with the aim of getting as many 
analytical categories and theoretical expla-
nations from the transcripts as possible. The 
analysis followed the usual five-step process: 
information gathering, theme identification, 
coding/indexing, structuring and interpre-
tation.24
Results
After reviewing the data, identifying a 
thematic framework, indexing, charting, 
mapping and interpretation, three categori-
es of statements with a subset of 10 themes 
were identified.
Attitudes of patients to PIL
Participants usually read PILs. A majo-
rity only read specific parts of PILs, which 
mainly depended on their focus of interest. 
Patients are interested in side effects, contra-
indications and how the medicines function. 
Some of them are interested in the chemical 
composition of the drug. All of them stres-
sed that in case of drugs for children they 
read PILs in total.
Patients who wish to know the medicine 
and in case of dissatisfaction with a doctor’s 
explanation were the most interested in re-
ading PILs. Patients were convinced that 
bad experiences reported by other patients 
raised the necessity of reading PILs. In case 
of OTC drugs, the majority of patients paid 
greater attention to PILs. They shared the 
opinion that using more medicines would 
make them read PILs.
There was an interesting common state-
ment that respecting the PILs depends on 
the prescribed medication. Antibiotic PILs 
are well respected. Some of the patients also 
respected PILs in order to get the desired 
treatment outcomes.
Quality of PILs
A majority of patients agreed that the 
information in PILs was not easy to un-
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derstand and were too complex for a non-
-professional readership. There was a lot of 
criticism regarding the font size and paper 
quality. The majority of proposals were made 
regarding the writing style. Some proposed 
a change of the size of the sheet. All the in-
terviewed patients agreed that the most im-
portant information should be marked in 
bold. The general opinion was that PILs do 
not offer useful information to majority of 
patients.
Surprisingly, patients shared a satisfac-
tion with the PILs in case that they do not 
have possibilities do get information elsew-
here.
Table 1: Results of the qualitative analysis
Categories Themes Patients’ quotations
First category: 
Patients’ attitude to 
reading PIL
Theme 1: 
Reading PILs
“I read the contraindications section.”; “I read the side effects section.; “…if I 
do read them, then I read the whole PIL.”
Theme 2: 
Relevant part of PILs
“I read about side effects.”; “…always but contraindications.”; “I am 
interested in how it (drug) works...”; “…for sure for kids, I always read in 
total.”; “I check the composition, then if there are any allergies…”; “I check 
if there is anything new.”; “I am interested in what the drug is for and if it 
is safe when driving a car or operating machinery.”; “I always check expiry 
date. Seriously…, yes, same as in sausages.”
Theme 3: 
Factors influencing 
decision to read PILs
“...if I understood my doctor well, I would not read (PILs) anymore...”; “My 
doctor’s advice is a rule for me …”; “I went to a pharmacy, explained my 
needs, and they gave me the wrong thing … yes, so in my experience, you 
must sometimes read (PILs).”; “…if the medicine is new, of course you 
read…”; “I would read due to my knowledgeable character…”; “…I check a 
little bit more, if I buy an OTC drug … what medicine you can combine it 
with.”; “…if I were to take more medicines at the same time, I would certainly 
read if they are compatible.”
Theme 4: 
Adherence to the PIL
“I always adhere to the information when using antibiotics… with other 
drugs I am probably less strict.”; “…depends on the medication.”; “I follow 
(advice) when I must, when taking antibiotics, I am very careful in following 
advice.”
Second category: 
Quality of PILs
Theme 1: 
Usefulness of data in PILs
“They (PILs) do not mean anything to me.”; “…not meant for a lay 
readership. They are more appropriate for healthcare professionals.”; “…
when you read, you start to imagine, hey, hey, I am really dizzy.”; “The 
usefulness is minor, but it makes people unsecure a lot.”;
Theme 2: 
Legibility of PILs
“A very small font size, the elderly are very pissed…”; “The paper is of low 
quality.”; “A lot of information on a small sheet of paper.”
Theme 3: 
Satisfaction with PILs
“This kind of information should stay attached to the drugs.”; “I agree that 
it is structured well, considerably satisfying.”; “If something happens during 
the night, good Lord, why should I be worried… PILs are always there to 
read…”
Theme 4: 
Views and proposal for the 
improvement of PILs
“It should be in bold, if it should be taken before a meal, on an empty 
stomach or… those items should be in bold.”; “It must be stressed, how to 
take medication, with how much liquid… some take drugs with ‘caffe au 
lait’.”; “…less complicated, easier understandable, less text…” ; “What really 
matters should be in bold..”; “…paper size should be A4...”
Third category: 
Getting the most 
reliable information 
on medicines
Theme 1: 
Actions taken in case of 
unclear information in 
PILs
“I call the doctor…”; “ My doctor is a low…”; “I stop medication and make 
an appointment with my family doctor.”; “I will not take medication; if I was 
on a sick leave, then I would take it…”; “I continue until there is something 
critical.”; “Let’s say, if I have some specific question, I ask pharmacist or 
mybe a nurse.”; “…I surf the Internet, there is much more information.”;
Theme 2: 
Other professionals 
who can offer useful 
information
“Let’s say, if I have some specific question, I ask pharmacist.”; “Information 
point with somebody who knows medications very well would be useful.”; 
“…abroad, clinical pharmacists are counsellors to patients and to 
physicians.”; “In hospital, there are clinical pharmacists.”
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Getting the most reliable 
information on medicines
The patients were sharing common views 
on seeking additional information with a fa-
mily doctor. Many also mentioned other so-
urces such as the Internet and magazines. A 
majority of patients were critical regarding 
unclear information in PILs, but only a few 
of them stopped taking prescribed drugs. 
Some of them expressed complete trust in 
what their doctors had prescribed and po-
inted out the necessity of additional infor-
mation in the area of consumerism. Patients 
told that they sometime get information on 
a drug from the nurse or the pharmacist and 
considered that (clinical) pharmacists sho-
uld be more important counsellors regar-
ding the use of medicines as they experien-
ced abroad.
Discussion
Methods
We have chosen focus groups (FGs) to 
elucidate patients’ views and their attitudes 
because group interactions provide more 
responses and convey more views than a 
simple interview or a questionnaire.22 FGs 
consisted of 6, 5, 4 and 5 participants, respec-
tively and achieved the required number of 
4–12 participants.22 We finished recruiting 
new focus groups when no new ideas arose 
during the discussion. The sample size was 
not determined by statistical rules but by 
others factor, such as representativeness of 
the participants (they know the scope, know 
how to express their own views) and data 
saturation. However, a sample of 20 partici-
pants was representative for the aim of the 
research and focus group study was conclu-
ded with the saturation of data.22-24 Further, 
different ideas could be gathered if some 
special social group were included in the re-
search i.e. homeless people or members of a 
Roma community.
Analysing the data
Text analysis was integrated with the 
observer’s notes (non-verbal communicati-
on, emphasis of specific topics, clarity of the 
views expressed) and triangulation during 
analysis was performed. Patients responded 
with short sentences, which can indicate 
that they were unfamiliar with some of the 
topics discussed in the study. The resear-
chers have found that patients emphasised 
the necessity of individual communication 
with the family doctor much more frequen-
tly than with e. g. a pharmacist or a nurse. 
Although the frequency of a specific answer 
is not important in a qualitative analysis, we 
can deduce that individual communication 
is important for patients.
The patient information 
leaflets (PILs)
Our findings confirmed the results of 
previous studies that patients read different 
parts of PILs.9 In Slovenia, patients are mo-
stly interested in the purpose of a prescri-
bed drug, about the regimen of medication 
and the side effects. In fact, patients seem 
to ignore the information in the PIL, which 
they do not understand. Generally, patients 
express satisfaction with specific parts of 
PIL which they had read and they did not 
highlight any new item compared to other 
studies.25,26 This general view indicates a 
rather low degree of patients’ awareness that 
PILs offer much more information and that 
they can do more for safety of medication by 
adhering to instructions.
Surprisingly, they pay much more atten-
tion to PILs for antibiotics than those for 
more potent drugs which have more side 
effects. This could be the result of a well-
-designed social media campaign about the 
rational use of antibiotics in recent years or 
the result of the patients’ belief that the use 
of antibiotics is linked to a serious disease.
Patients, who did not get adequate in-
formation about a prescribed drug from 
their doctor, were more often forced to read 
PILs. On the other hand, patients seek deta-
iled information from their family doctors 
when the information in PILs is not under-
standable. This is in line with the findings 
of other studies, which reported that some 
PILs confuse patients’ understanding.13 We 
can anticipate that patients who fail to ob-
tain satisfactory answers from either source 
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would stop taking the prescribed medicati-
on. Moreover, health-care professionals,27 
the Internet28 and other media29 are con-
sulted in case of ambiguous information in 
PILs, which supports the view of patients 
that PILs should include more understanda-
ble phraseology for lay readers.13,14 Also, the 
design, i.e. use of font and bold text can gui-
de patients to read the most important parts 
of PILs.26 Therefore, being advised to read 
PILs by their physicians would not improve 
patients’ knowledge on drugs.
In spite of the general opinion that the 
PILs are difficult to understand, the majo-
rity of patients find the information they 
need. That may denote a low level of preten-
tiousness of patients to the content of PILs; 
patients can find out partial information in 
every PIL but they are usually unable to un-
derstand the content in its entirety. There-
fore, encouraging patients to pay attention 
to PIL would not improve their understan-
ding of medicine. Conversely, it can confuse 
patients or arise a number of questions that 
need to be discussed with a family doctor. 
According to this study, PILs do not render a 
time consuming doctor-patients communi-
cation on drug more efficient, and therefore 
other options have to be sought to improve 
patients’ knowledge on drugs. The role of 
family doctors in informing patients regar-
ding medication is stressed in each PIL by 
directing patients to consult their doctors in 
case they need any further information (‘In 
case you need any further information, con-
sult your doctor’), thus referring patients to 
communicate with them.27,30,31 The lack of 
family practitioners and the huge frequency 
of patients’ visits a day makes it impossible 
to inform patients successfully.2,3
Trustworthy information
Good information on drugs enables bet-
ter adherence of patients to the directions 
and continuity of intake of medicines. In 
Slovenia, patients mainly asked the family 
physicians for more detailed information, 
therefore doctor-patient communication 
time should be extended and GPs also have 
to adjust their communication skills to the 
patients’ expectations.
In practice, the number of daily GP-pati-
ent contacts is very high and spending more 
time with every patient in an already busy 
timetable is impossible.3 Currently, an incre-
ase in the workload is unacceptable for GPs. 
Due to the lack of doctors it is not possible 
to recruit new ones and the only way to sol-
ve this problem would be by involving an 
additional expert to do the consultancy on 
drugs.
The pharmacists
In Slovenia, there are no clinical phar-
macists on the primary health care level 
yet although their presence would be very 
helpful and, according to the studies, the 
following services for this setting can be 
suggested: medication reconciliation, medi-
cation review, patient education, promotion 
of compliance, and involvement in the treat-
ment.32,33 Some studies have also indicated a 
significant impact of pharmaceutical care on 
health outcome improvements, knowledge, 
medication adherence, medication beliefs 
and significant reduction in hospital admis-
sion rates.34 Also, GPs could contact them 
while prescribing medicines. A health care 
team (e. g. a GP, a nurse, a clinical specialist 
and a pharmacist) could be more efficient 
at educating people about the importance 
of regular medical treatment, while the role 
of pharmacists and inter-professional col-
laborative practice in patient care from the 
economic, humanistic, efficacy, and safety 
perspectives remains a subject for future re-
search.35,36
Conclusion
The results of this study indicate that pa-
tients most appreciate information on dru-
gs that are given by the experts in personal 
contact. Although PILs seemed to be a good 
source of information, patients do not con-
sider them as sufficient. Additionally, rea-
ding PILs often results in patients’ concern 
and therefore triggers further questions that 
require additional GP’s time, otherwise in-
tended for treatment and consultation. That 
could be a reason why physicians do not en-
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courage patients to read written information 
on medicines.
To date, the most reliable source of infor-
mation on the use and effect of medicines 
have been doctors themselves. The obstacle 
of the doctors’ lack of time could be reduced 
by using an effective computer programme 
on medicines and their interactions, and by 
the decision to supplement the health care 
team at the primary care level with additio-
nal experts. The study has shown that health 
care policy in Slovenia could foster more ac-
tive involvement of a pharmacist as an im-
portant additional consultant on medicati-
on and education of patients in the primary 
care setting.
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